Ambry Genetics Buys an Illumina Genome Analzyer

May 05, 2008

NEW YORK (GenomeWeb News) – Ambry Genetics said Friday that it has purchased a Genome Analyzer from Illumina that it plans to use in conducting pharmacogenomics services for customers.

The Aliso Viejo, Calif.-based genetic testing firm said that it has already begun running research samples on the GA with its probe capture technology.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

In the Pink

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

All Tied Up in a Bow

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

This Week in PNAS

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

When the Ailment You're Studying Becomes Personal

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

Main menu